PharmaBlock Sciences (Nanjing), Inc. (300725.SZ)
| Previous close | 33.65 |
| Open | 33.56 |
| Bid | 34.73 x 0 |
| Ask | 34.74 x 0 |
| Day's range | 34.05 - 34.90 |
| 52-week range | 23.25 - 55.98 |
| Volume | |
| Avg. volume | 7,653,114 |
| Market cap | 6.936B |
| Beta (5Y monthly) | 0.52 |
| PE ratio (TTM) | 37.35 |
| EPS (TTM) | 0.93 |
| Earnings date | N/A |
| Forward dividend & yield | 0.10 (0.30%) |
| Ex-dividend date | 13 Jun 2023 |
| 1y target est | 52.00 |
PR NewswirePharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
PharmaBlock (Stock code: 300725.SZSE), a global, fully integrated CRDMO with a focus on innovative chemistry and low-carbon manufacturing, is proud to announce that it has been awarded the 2024 CMO Excellence in Green Chemistry Award by the American Chemical Society (ACS) Green Chemistry Institute Pharmaceutical Roundtable (GCI PR). This esteemed award, marking the company's second consecutive win among global CDMO companies, is a testament to PharmaBlock's persistent commitment to green chemist
PR NewswirePharmaBlock Opens HPAPI GMP Facility at Zhejiang Manufacturing Site
PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has announced opening of a new high potency API (HPAPI) GMP facility (OEB-5 and above) at its Zhejiang manufacturing site.
PR NewswirePharmaBlock Obtained ISO 50001 Certification, Advancing Sustainable Development
PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725. SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has announced the successful attainment of Energy Management System Certification (ISO 50001:2018) for its headquarters and R&D center in Nanjing, as well as its manufacturing facilities in Zhejiang and Shandong, China. This achievement illustrates PharmaBlock's ongoing dedication to lean operations, energy efficiency, and susta
